Alaunus Biosciences

South San Francisco, CA · Medtech

A multi-analyte diagnostic assay measuring protease activity and mass-based biomarkers in thyroid fine needle aspirates to differentiate malignant from benign nodules.

alaunusbio.com →
Grants
$4.1M
7 awards
Sector median: 1
Raised
—
No Form D on record
Contracts
—
No federal contracts on record
Patents
3
0 granted · 3 pending
Sector median: 2

Capital Timeline

Federal above the line · equity below · node area scaled to amount
Capital and federal award history
DateEventSourceAmount
Federal grant· 1 of 2 same dayDepartment of Health and Human Services · Phase I · Development of fluorogenic substrates for the diagnosis of pancreatic cysts$235,341
Federal grant· 2 of 2 same dayDepartment of Health and Human Services · Phase I · Development of fluorogenic substrates for the diagnosis of pancreatic cysts$235,341
Federal grantDepartment of Health and Human Services · Phase I · Development of activity-based biomarkers for risk stratification of indeterminate thyroid nodules$264,718
Federal grantDepartment of Health and Human Services · Phase I · Development of activity-based biomarkers for risk stratification of indeterminate thyroid nodules$264,718
Federal grantDepartment of Health and Human Services · Phase II · Development of a multi-analyte diagnostic assay to improve the risk stratification of indeterminate thyroid nodules$1,567,219
Federal grantDepartment of Health and Human Services · Phase II · Development of a multi-analyte diagnostic assay to improve the risk stratification of indeterminate thyroid nodules$871,193
Federal grantDepartment of Health and Human Services · Phase II · Development of a multi-analyte diagnostic assay to improve the risk stratification of indeterminate thyroid nodules$696,026
Federal grant · SBIR/STTR

Peer position

Medtech · 4531 companies · ranked on federal contract value
Medtech companies ranked by federal contract value
#CompanyContractsDisclosed equity
1356VIVARAY INC—$600K
1357Sonendo, Inc.—$238M
1358LAP IQ, INC.——
1359Alaunus Biosciences——
1360CONSENSUS NETWORKS INC.——
1361BIODATA CONSORTIUM, LLC——
1362ROKHAN, LLC——

Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.

Patents

USPTO · 0 granted of 3
  • Peptidase Cleavable Substrates And Methods Of Identification And Use Thereofapplication
  • Peptidase Cleavable Substrates And Methods Of Identification And Use Thereofapplication
  • Peptidase Cleavable Substrates And Methods Of Identification And Use Thereofapplication

Regulatory activity · Medtech

Sector-level, not company-level

Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.